Under the new law, licensed Florida physicians may administer ACP-01 (VesCell) for ischemia-related pain in conditions such ...

David Mays, a cancer survivor, is dying — but he's at peace with his fate because he's got friends, love and support.

InterShunt Technologies has initiated the EASE HF2 early feasibility study to assess the InterShunt percutaneous atrial shunt ...

InterShunt Technologies announced today that it began an early feasibility study of its device for reducing heart failure symptoms.

Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced it has won 21 Digital Health Awards in ...

Margaret Van Bruggen’s family had just 24 hours to decide whether to let Duke surgeons perform a heart-valve-transplant surgery that had never been done before.

VisCardia’s therapy, Synchronized Diaphragmatic Stimulation (SDS), represents a new paradigm in heart failure management by harnessing cardio-respiratory interactions to augment cardiac performance.

Research Triangle Park, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- First-in-human trial of AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart Association ...

Optimized treatment can reduce the mortality risk for chronic heart failure (HF) by as much as 60%. The role of appropriate drug combinations and rapid diagnosis was discussed at the 91st Annual ...

Can a broken heart kill you? Men are twice as likely to die from the stress-related heart condition commonly called "broken heart syndrome" compared to women, according to new research.